Friday, May 24, 2019 8:39:58 AM
Over the past 4 years there have been several VERY significant spikes mostly occurring in the latter or going into the latter part of the year. The company has no revenue and is under funded (especially for an R&D company in the medical sector). What accounts for the spike with no PR to coincide with and why are spikes occurring ahead of PR's? The spikes are rather consistent as well with the them averaging many thousands of percentile increases in very sudden market liquidity present. I understand that the daily dollar volume tells a different story but some metrics are difficult to ignore especially ones that create a market or environment to sell into.
I know I am jaded but this really implies stock promo activity from an OTC Pink which concerns me. Looking at the financials the company has had no revenue with no cash position to support operations or development. I simply can not account for the companies market without management paying for a promotion. This of course can be very toxic because they obviously dont have cash which means they are paying with stock. The O/S has nearly quadrupled in the past year alone! Thats a significant dilution to the market which is reflected in the 1,600% share loss over the last 12 months!
I will admit that I do not typically invest in OTC companies but have recently begun to delve into this micro cap market with skepticism so please excuse any offense my posts may bring. On the surface the company looks VERY interesting but unfortunately that is the case with many companies and OTC companies tend to prove disappointing more often than not. To be blunt most OTC CEO's are not genuine in their intent with personal income consuming the bulk of their focus. I would like to think the best of this management but something is not adding up here. Hopefully I am wrong and someone here can help shed light on my mistake.
Again any help with RMSL would be greatly appreciated. I was strongly considering a block position in this company and would like to confirm a few things before deciding either way. Thanks in advance!
Recent RMSL News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 07:23:42 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/14/2024 01:10:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:18 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 09:58:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:38:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:26:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 07:02:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:10:55 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:12:01 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 01:58:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2023 07:21:17 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM